Loading
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (7 ops.)
Latest filing published 12 Dec 2024 for Scholar Rock Holding Corp, €63.1M. Read the official filing
Filing timeline
BuySaleInvus Public Equities, L.P.
Insider track record
Disclosed buys
10
Disclosed sells
7
T+90 hit rate
60%
T+90 mean return
+35.8%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Invus Public Equities, L.P.: trading record in brief
Filings by Invus Public Equities, L.P. span 3 companies, the busiest being Crescent Biopharma, Inc., Scholar Rock Holding Corp and Omega Therapeutics, Inc. Between 30 July 2021 and 10 December 2024, the trades on record add up to 17 filings.
The open-market side counts 10 purchases for €19.5M alongside 7 sales for €70.7M. Netting one side against the other leaves €51.3M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings no purchases and 6 sales.
The median purchase comes to €336k. Of 10 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 12 December 2024, reports an open-market sale of €63.1M in Scholar Rock Holding Corp. The most recent open-market purchase was published on 16 October 2023, 1,098 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Invus Public Equities, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
1,600,000 shares@ US$41.6572.8% of flowCommon StockSEC:0000950170-24-135847:0
208,272 shares@ US$37.63118.6% of flowCommon StockSEC:0000950170-24-131539:0
61,488 shares@ US$0.18210.4% of flowCommon StockSEC:0000950170-24-094800:0
164,523 shares@ US$0.18841.2% of flowCommon StockSEC:0000950170-24-092864:0
63,564 shares@ US$0.21620.5% of flowCommon StockSEC:0000950170-24-090910:0
258,335 shares@ US$0.24172.4% of flowCommon StockSEC:0000950170-24-088020:0
2,189,781 shares@ US$6.8516.4% of flowCommon StockSEC:0000950170-23-053600:0
Canonical exit: 10 Jan 2024 (T+90)
31,557 shares@ US$6.42790.2% of flowCommon StockSEC:0000899243-23-012043:0
Canonical exit: 27 Jul 2023 (T+90)
100,000 shares@ US$1.706.7% of flowCommon StockSEC:0000899243-23-006426:0
Canonical exit: 25 May 2023 (T+90)
50,000 shares@ US$1.853.6% of flowCommon StockSEC:0000899243-23-006027:0
Canonical exit: 22 May 2023 (T+90)
1,000,000 shares@ US$2.155883.7% of flowCommon StockSEC:0000899243-23-005502:0
Canonical exit: 16 May 2023 (T+90)
11,451 shares@ US$3.24191.4% of flowCommon StockSEC:0000899243-23-004819:0
Canonical exit: 10 May 2023 (T+90)
1,094 shares@ US$9.4820.0% of flowCommon StockSEC:0000899243-23-001634:0
48,774 shares@ US$9.33060.5% of flowCommon StockSEC:0000899243-23-001307:0
Canonical exit: 5 Apr 2023 (T+90)
130,265 shares@ US$8.04041.2% of flowCommon StockSEC:0000899243-22-034318:0
Canonical exit: 23 Jan 2023 (T+90)
33,971 shares@ US$7.02920.3% of flowCommon StockSEC:0000899243-22-033263:0
Canonical exit: 1 Jan 2023 (T+90)
75,000 shares@ US$16.1379100.0% of flowCommon StockSEC:0000899243-21-031304:0
Canonical exit: 28 Oct 2021 (T+90)
17 of 17 declarations
